|
04-13-2010, 06:17 AM
|
|||
|
|||
Tengion gets $30 million on its stock IPO
Tengion Inc. has completed its initial public offering, attracting $30 million from investors by providing more shares at a lower price.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Tengion Adds The Johns Hopkins Hospital As An Additional Clinical Trial Site For Its | cancerfr | Bladder Cancer | 0 | 09-11-2010 03:26 AM |
| Johns Hopkins added as second clinical trial site in Tengion Neo-Urinary Conduit Phas | cancerfr | Bladder Cancer | 0 | 09-11-2010 03:26 AM |
| Tengion Adds The Johns Hopkins Hospital as an Additional Clinical Trial Site For Its | cancerfr | Bladder Cancer | 0 | 09-10-2010 03:47 AM |
| Tengion reports quarterly loss after going public | cancerfr | Bladder Cancer | 0 | 08-13-2010 03:59 AM |
| Tengion expects to raise up to $44.4M in IPO | cancerfr | Bladder Cancer | 0 | 04-06-2010 09:15 PM |
Linear Mode
